综合肝细胞 - 胆管癌的系统治疗策略:当前的证据和未来的方向
1Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Journal of liver cancer
|February 26, 2026
概括
结合性肝细胞胆管癌 (cHCC-CC) 是一种具有复杂生物学特征的罕见肝癌. 研究强调,由于其异质性,需要个性化治疗,免疫疗法和向药物显示出希望.
科学领域:
- 肝胆道恶性瘤 肝胆道恶性瘤
- 翻译性瘤学 翻译性瘤学
- 癌症基因组学 癌症基因组学
背景情况:
- 结合性肝细胞胆管癌 (cHCC-CC) 是一种罕见的,具有双重分化的原发性肝癌.
- 它的稀有性,诊断复杂性和细胞可塑性阻碍了标准化的全身治疗策略.
- 瘤具有重叠的分子特征与肝细胞癌和肝内胆管癌,有助于治疗反应的变化.
研究的目的:
- 审查目前对cHCC-CC的系统性治疗策略.
- 探索新兴的治疗方法和生物标志物的作用.
- 确定优化治疗模式的未来方向.
主要方法:
- 对回顾性分析和临床试验数据的审查.
- 分子和病理学研究的分析.
- 检查新兴的治疗平台和多模式策略.
主要成果:
- 基于的化疗提供了适度但一致的息作用.
- 免疫疗法和抗血管原剂显示出令人鼓舞的抗瘤作用.
- 综合局部区域和系统疗法的多模式策略正在获得引力.
结论:
- 由于其异质性,cHCC-CC的标准化系统治疗方法尚未定义.
- 生物标记驱动的方法,分子分层和理性组合对于未来的进步至关重要.
- 需要进一步的研究和特定疾病的试验,以建立最佳的治疗模式.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.6K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.3K
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Chronic Pancreatitis II: Collaborative Care
435
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
435
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
